<- Go Home
Silk Road Medical, Inc
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. As of September 17, 2024, Silk Road Medical, Inc operates as a subsidiary of Boston Scientific Corporation.
Market Cap
$1.1B
Volume
1.2M
Cash and Equivalents
$22.6M
EBITDA
-$57.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$142.2M
Profit Margin
74.28%
52 Week High
$27.51
52 Week Low
$6.08
Dividend
N/A
Price / Book Value
7.22
Price / Earnings
-19.06
Price / Tangible Book Value
7.22
Enterprise Value
$1.0B
Enterprise Value / EBITDA
-17.89
Operating Income
-$60.2M
Return on Equity
36.45%
Return on Assets
-14.11
Cash and Short Term Investments
$172.0M
Debt
$84.5M
Equity
$154.7M
Revenue
$191.4M
Unlevered FCF
-$11.3M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium